Close Menu

NEW YORK (GenomeWeb) – Two letters to the editor of the New England Journal of Medicine have pointed out possible flaws or omissions in a recent paper that suggested that a gene test could guide breast cancer treatment decisions.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
27
Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.